Five-year Outcome of CD19 Combined With CD22 CAR-T Cell Therapy in Patients With B-ALL Relapsed After Allo-transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Five-year Outcome of CD19 Combined With CD22 CAR-T Cell Therapy in Patients With B-ALL Relapsed After Allo-transplantation

Published:2024-07-25 Issue: Volume: Page:46-48
ISSN:2053-6631
Container-title:EMJ Hematology
language:
Short-container-title:EMJ Hematol

Author:

Liu Shuangyou¹,An Lihong¹,Yin Zhichao¹,Lin Yuehui¹,Lin Zhuojun¹,Deng Biping²,Yu Xinjian³,Zheng Qinlong³,Zhao Defeng¹,Wu Tong⁴,Chang Alex⁵,Tong Chunrong¹

Affiliation:

1. Department of Hematology, Beijing Boren Hospital, China

2. Cytology Laboratory, Beijing Boren Hospital, China

3. Medical Laboratory, Beijing Boren Hospital, China

4. Department of Bone Marrow Transplantation, Beijing Boren Hospital, China

5. Engineering Research Center of Gene Technology, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China

Publisher

European Medical Group

Reference4 articles.

1. Spyridonidis A et al. Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT. Leukemia. 2012;26(6):1211-7.

2. Park JH et al. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N Engl J Med. 2018;378(5):449-59.

3. Maude SL et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N Engl J Med. 2018;378(5):439-48.

4. Liu S et al. Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation. Am J Hematol. 2021;96(6):671-9.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP